New Delhi, Feb. 3 -- Pharmaceutical firm Alembic Pharma today reported over 23 per cent drop year-on-year in net profit at Rs 138.42 crore for the third quarter (October-December) of current fiscal 2024-25, versus Rs 180.45 crore posted in same quarter of previous financial year.
The total revenues from operations grew about 4 per cent year-on-year at Rs 1,692.74 crore in the third quarter as against Rs 1,630.57 crore in the corresponding quarter of last financial year, the company said in a regulatory filing with the stock exchanges.
Mr. Shaunak Amin, MD, Alembic Pharmaceuticals Limited said "In the current quarter, we faced market headwinds in the acute segment. However, other key therapies in our specialty business continued to outpace...